MedPath

Nocturnal Insulin-Glucose in Hospital: Tight Control

Not Applicable
Completed
Conditions
Type 1 Diabetes
Registration Number
NCT02160184
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria

Inclusion Criteria:<br><br> - Type 1 Diabetes<br><br> - Diabetes duration > 3 years<br><br> - Continuous Subcutaneous Insulin Infusion (CSII) treatment for more than 1 year<br><br> - A1c 6-9%<br><br> - No ketoacidosis during the previous 12 months<br><br> - Glomerular Filtration Rate (GFR) > 60 ml/kg/min m2<br><br> - Willingness of participate and signed and dated written informed consent in<br> accordance with Good Clinical Practice<br><br>Exclusion Criteria:<br><br> - Gastroparesis<br><br> - Hypoglycemia unawareness<br><br> - Uncorrected visual impairment<br><br> - Deafness<br><br> - BMI> 35 kg/m2

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of time in target range (3.9-8.0 mmol/l) YSI glucose during the in clinic overnight visit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath